Skip to main content
Premium Trial:

Request an Annual Quote

Agilent Debt Rating Affirmed, Outlook Raised

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Fitch Ratings has affirmed its ratings on Agilent Technologies' debt and has revised its outlook to 'positive' from 'stable.'

The Chicago-based rating agency affirmed Agilent's Issuer Default Rating of 'BBB,' as well as a 'BBB' rating on the firm's senior unsecured revolving credit facility and its senior unsecured notes.

Fitch said that it raised its outlook on Agilent due to "greater confidence in Agilent's operating and financial profile. The company's increasing percentage of organic sales from the faster growing and more profitable Life Sciences and Chemical Analysis segments should drive higher and less uneven operating performance over time," Fitch said in a statement.

The agency also cited Agilent's recently completed $1.5 billion acquisition of Varian as a catalyst for greater revenues in its Life Sciences and Chemical Analysis segments.

The Scan

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.

DNA Biobank Developed for French Kidney Donors, Recipients

The KiT-GENIE biobank described in the European Journal of Human Genetics contains DNA samples, genotyping profiles, immune patterns, and clinical features for thousands of kidney donors or transplant recipients in Nantes, France.

Cardiometabolic Disease May Have Distinct Associations With Microbial Metabolites in Blood, Gut

By analyzing gut microbes in combination with related metabolites in feces and blood, researchers in Nature Communications found distinct cardiometabolic disease relationships at each site.

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.